Versioned analysis structure
Pipeline selection, parameter control, organism-specific workflow notes, run metadata, and repeatable execution patterns.
Validation-aware implementation
Theiagen helps commercial labs define the analysis, review, documentation, and reporting structure that supports validation planning and operational adoption.
Where launches get stuck
A commercial pathogen-genomics service needs reproducible workflow execution, QC thresholds, version control, metadata discipline, technical review, interpretation guardrails, and documentation that can survive internal scrutiny.
Theiagen does not turn a pilot into a finished regulatory validation. We help build the evidence structure, workflow discipline, and reporting model that your lab can evaluate within its own quality system.
Support areas
Pipeline selection, parameter control, organism-specific workflow notes, run metadata, and repeatable execution patterns.
Checkpoint design for read quality, coverage, contamination, lineage or taxon calls, AMR evidence, relatedness review, and exception handling.
Clear output categories, technical limitations, customer-facing language boundaries, escalation notes, and scientific review expectations.
Run summary structure, workflow provenance, data inputs, software versions, quality notes, and reviewer signoff patterns.
Training for technical staff, scientific directors, support teams, and commercial teams so outputs are used consistently.
Service-line readiness, role clarity, support workflows, customer education, and next-step roadmap after pilot review.
Validation-ready output structure
Sample context, sequence files, metadata, and accepted run conditions.
Pipeline version, parameters, reference data, and execution environment.
Pass, warn, fail, rerun, and escalation criteria for scientific review.
Structured evidence, context, limitations, and confidence boundaries.
Executive summary, technical appendix, and operational evidence record.
Launch artifact
Use the checklist to align scientific, operational, and commercial teams before a pilot starts. The goal is to define what needs to be true for a broader service launch.
Validation-first pilot
Theiagen can help turn a pathogen-genomics launch idea into a validation-aware pilot plan.
Bring the organism, customer use case, and current workflow. We will help identify the evidence structure your pilot should produce.